Glucosephosphate Dehydrogenase
"Glucosephosphate Dehydrogenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D005954
|
| MeSH Number(s) |
D08.811.682.047.150.300
|
| Concept/Terms |
Glucosephosphate Dehydrogenase- Glucosephosphate Dehydrogenase
- Dehydrogenase, Glucosephosphate
- Glucose-6-Phosphate Dehydrogenase
- Dehydrogenase, Glucose-6-Phosphate
- Glucose 6 Phosphate Dehydrogenase
|
Below are MeSH descriptors whose meaning is more general than "Glucosephosphate Dehydrogenase".
Below are MeSH descriptors whose meaning is more specific than "Glucosephosphate Dehydrogenase".
This graph shows the total number of publications written about "Glucosephosphate Dehydrogenase" by people in UAMS Profiles by year, and whether "Glucosephosphate Dehydrogenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucosephosphate Dehydrogenase" by people in Profiles over the past ten years.
-
Vassy JL, Stone A, Callaghan JT, Mendes M, Meyer LJ, Pratt VM, Przygodzki RM, Scheuner MT, Wang-Rodriguez J, Schichman SA. Pharmacogenetic testing in the Veterans Health Administration?(VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee. Genet Med. 2019 02; 21(2):382-390.
-
Debeb BG, Lacerda L, Larson R, Wolfe AR, Krishnamurthy S, Reuben JM, Ueno NT, Gilcrease M, Woodward WA. Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism. Oncotarget. 2016 May 10; 7(19):28329-39.